Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Retinol-binding protein 7 is an endothelium-specific PPARγ cofactor mediating an antioxidant response through adiponectin
Chunyan Hu, … , Frederick W. Quelle, Curt D. Sigmund
Chunyan Hu, … , Frederick W. Quelle, Curt D. Sigmund
Published March 23, 2017
Citation Information: JCI Insight. 2017;2(6):e91738. https://doi.org/10.1172/jci.insight.91738.
View: Text | PDF
Research Article Vascular biology

Retinol-binding protein 7 is an endothelium-specific PPARγ cofactor mediating an antioxidant response through adiponectin

  • Text
  • PDF
Abstract

Impaired PPARγ activity in endothelial cells causes oxidative stress and endothelial dysfunction which causes a predisposition to hypertension, but the identity of key PPARγ target genes that protect the endothelium remain unclear. Retinol-binding protein 7 (RBP7) is a PPARγ target gene that is essentially endothelium specific. Whereas RBP7-deficient mice exhibit normal endothelial function at baseline, they exhibit severe endothelial dysfunction in response to cardiovascular stressors, including high-fat diet and subpressor angiotensin II. Endothelial dysfunction was not due to differences in weight gain, impaired glucose homeostasis, or hepatosteatosis, but occurred through an oxidative stress–dependent mechanism which can be rescued by scavengers of superoxide. RNA sequencing revealed that RBP7 was required to mediate induction of a subset of PPARγ target genes by rosiglitazone in the endothelium including adiponectin. Adiponectin was selectively induced in the endothelium of control mice by high-fat diet and rosiglitazone, whereas RBP7 deficiency abolished this induction. Adiponectin inhibition caused endothelial dysfunction in control vessels, whereas adiponectin treatment of RBP7-deficient vessels improved endothelium-dependent relaxation and reduced oxidative stress. We conclude that RBP7 is required to mediate the protective effects of PPARγ in the endothelium through adiponectin, and RBP7 is an endothelium-specific PPARγ target and regulator of PPARγ activity.

Authors

Chunyan Hu, Henry L. Keen, Ko-Ting Lu, Xuebo Liu, Jing Wu, Deborah R. Davis, Stella-Rita C. Ibeawuchi, Silke Vogel, Frederick W. Quelle, Curt D. Sigmund

×

Figure 9

Model Illustrating the PPARγ/RBP7/adiponectin transcriptional hub.

Options: View larger image (or click on image) Download as PowerPoint
Model Illustrating the PPARγ/RBP7/adiponectin transcriptional hub.
PPARγ...
PPARγ is a nuclear transcription factor that induces expression of retinol-binding protein 7 (RBP7), an endothelium-specific PPARγ target gene. RBP7 facilitates transcriptional activation of RBP7-dependent PPARγ target genes including adiponectin (AdipoQ). Expression of these genes is impaired in the absence of RBP7. Expression of AdipoQ mediates an antioxidant response when the mice are challenged with either high-fat diet (HFD) or angiotensin II (Ang-II). Impairment of this protective response under conditions where either RBP7 or PPARγ is impaired causes oxidative stress and endothelial dysfunction in the presence of cardiovascular stressors.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts